Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This man-made peptide resembles the actions of naturally present GLP-1, a hormone https://mysocialport.com/story6325216/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes